Lyophilization — commonly known as freeze-drying — is the standard method for preserving synthetic peptides in a stable, solid-state form suitable for long-term storage and transportation. The process removes water from a frozen peptide solution through sublimation under vacuum, producing a dry, porous cake that can be reconstituted when needed for research applications.
The Three Phases of Lyophilization
A properly designed lyophilization cycle consists of three distinct phases, each critical to the quality of the final product:
1. Freezing
The peptide solution is cooled below its eutectic temperature — the point at which all components are fully solidified. For most peptide formulations in water or dilute buffer, shelf temperatures of -40°C to -50°C are employed. The freezing rate significantly impacts ice crystal morphology: rapid freezing produces small, uniform crystals that create a porous cake structure, while slow freezing produces larger crystals that may concentrate the peptide at crystal boundaries, potentially promoting aggregation.
2. Primary Drying
Chamber pressure is reduced to 50–200 mTorr while shelf temperature is gradually raised to -10°C to +10°C. Under these conditions, ice sublimes directly from solid to vapor without passing through a liquid phase. This sublimation step removes approximately 95% of the water content. The shelf temperature must remain below the product's collapse temperature — exceeding this causes the cake structure to collapse, resulting in poor reconstitution properties and potential chemical degradation.
3. Secondary Drying
After primary drying removes bulk ice, residual unfrozen water (bound to the peptide and excipients) must be removed through desorption. Shelf temperature is raised to +20°C to +40°C under maintained vacuum for several hours. The target is a final residual moisture content of 1–3% w/w — low enough to prevent hydrolytic degradation during storage, but not so aggressive as to remove structurally important water molecules that maintain peptide conformation.
Critical Process Parameters
Excipient Selection for Peptide Lyophilization
Most peptide lyophilization protocols include excipients that serve as cryoprotectants (protecting during freezing) and lyoprotectants (protecting during drying). Common choices include:
- Mannitol — Bulking agent that forms a crystalline matrix, providing elegant cake structure and mechanical strength
- Trehalose — Amorphous sugar that forms a glassy matrix around the peptide, replacing hydrogen bonds normally provided by water (the water replacement hypothesis)
- Sucrose — Similar lyoprotective function to trehalose with higher glass transition temperature when combined with other excipients
- Histidine/acetate buffers — pH maintenance during freezing concentration effects, preventing acid-catalyzed degradation
Stability-Indicating Degradation Pathways
Even in lyophilized form, peptides remain susceptible to several chemical degradation mechanisms that must be monitored during stability studies:
- Deamidation — Asparagine and glutamine residues can convert to aspartic/glutamic acid, detectable as +1 Da mass shifts
- Oxidation — Methionine and tryptophan residues are vulnerable to oxidation, producing +16 Da modifications
- Diketopiperazine formation — Cyclization of the first two N-terminal residues, particularly problematic for peptides beginning with proline
- Aggregation — Intermolecular disulfide bond formation or hydrophobic association during reconstitution
Storage Recommendations
Properly lyophilized peptides stored at -20°C under desiccated conditions can maintain >95% purity for 12–24 months, depending on the sequence. At AminoVita, all peptides are lyophilized using optimized cycle parameters specific to each compound's physicochemical profile, sealed under inert atmosphere, and shipped with cold-chain protocols to ensure researchers receive material of the highest integrity.